Recurrence patterns among our EGFR-positive NSCLC cohort were similar to those of the control arm of ADAURA.2 The optimum frequency and duration of surveillance for resected NSCLC remains undefined, including the implications of the presence of oncogenic drivers. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.